Olezarsen

Tryngolza

80 MG / 0.8 ML SolutionCanadaMarketedAuthorised 4 Feb 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Tryngolza 80 MG Solucion Inyectable en Pluma PrecargadaSpain · 80 mg · solución inyectable · Swedish Orphan Biovitrum Ab (Publ)Same brand
TryngolzaEuropean Union · Swedish Orphan Biovitrum AB (publ)Same brand
TryngolzaItaly · Soluzione iniettabile in penna pre-riempita · Swedish Orphan Biovitrum AB (Publ)Same brand
Tryngolza 80 mg oplossing voor injectie in een voorgevulde penNetherlands · Oplossing voor injectie · Swedish Orphan Biovitrum AB (publ)Same brand
Tryngolza (Autoinjector)United States · 80MG BASE/0.8ML · solution · Ionis Pharms INCSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Olezarsen

Tryngolza

80 MG / 0.8 ML SolutionCanadaMarketedAuthorised 4 Feb 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Olezarsen
Strength: 80 MG / 0.8 ML
Dosage form: Solution
Route: Subcutaneous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 4 Feb 2026
Registration: DIN 02563886
Marketing authorisation holder: Celystra Pharma INC.
ATC code: C10AX
Group: Cardiovascular system
Supply: PRESCRIPTION